Research programme: aminosterols - Genaera

Drug Profile

Research programme: aminosterols - Genaera

Alternative Names: MSI-1432; MSI-1433

Latest Information Update: 21 Jan 2010

Price : $50

At a glance

  • Originator Genaera Corporation
  • Class Small molecules; Sterols
  • Mechanism of Action T cell activation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Inflammation

Most Recent Events

  • 31 Mar 2008 Preclinical trials in Inflammation in USA (unspecified route)
  • 31 Mar 2008 Preclinical trials in Asthma in USA (Inhalation)
  • 15 May 2006 Preclinical trials in Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top